Reata Pharmaceuticals, Inc. (RETA) has a market capitalization of $6.57B and trades at $172.36. The 52-week range is 21.83-172.46.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -20.1, Earnings Per Share (EPS) of $-8.59, annual revenue of $2.22M.
The stock has a beta of 1.42, operates in the Healthcare sector.
